1. Clinico-pathological predictors of clinical complete response in rectal cancer. (2022) Authors: Mbanu, P.; Osorio, E. Vasquez; Mistry, H.; Malcomson, L.; Yousif, S.; Aznar, M.; Kochhar, R.; Van Herk, M.; Renehan, A.G.; Saunders, M.P. Journal: Cancer treatment and research communications Issue: Number 31(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is it Time to Look for Better Prognostic Markers and Reconsider Adjuvant Chemotherapy for Locally Advanced Anal Cancers?. Issue 10 (October 2021) Authors: King, J.; Swinton, M.; Grant, G.; Buckley, L.; Lavin, V.; Alam, N.; Saunders, M.P. Journal: Clinical oncology Issue: Volume 33:Issue 10(2021) Page Start: e465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial. (August 2019) Authors: Marti, F.E. Marti; Jayson, G.C.; Manoharan, P.; O'Connor, J.; Renehan, A.G.; Backen, A.C.; Mistry, H.; Ortega, F.; Li, K.; Simpson, K.L.; Allen, J.; Connell, J.; Underhill, S.; Misra, V.; Williams, K.J.; Stratford, I.; Jackson, A.; Dive, C.; Saunders, M.P. Journal: European journal of cancer Issue: Volume 117(2019) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗